sintilimab
Commercial- Indications
- Cancer
Company intelligence / Profile preview
Adimab
Lebanon, New Hampshire, United Statesadimab.com ↗
- Ownership
- Private
- Employees
- ~134
- Development stage
- Commercial
01
Overview
Adimab’s technology has enabled over 600 therapeutic programs with more than 130 partners. Over 75 clinical-stage programs have been created using the platform; several have reached approval via partner companies. The company itself does not report direct clinical results as it is a technology enabler rather than a product developer.
- Therapeutic areas
- OtherOncologyImmunologyInfectious Diseases
- Modalities
- Monoclonal antibodyBispecific monoclonal antibodyT cell engagerRecombinant protein
- Industry
- Drug Discovery Services
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →03
Partnerships
BiogenGSKLillyMerck & Co.Novo NordiskTakedaAlnylam PharmaceuticalsBristol Myers SquibbNovartisRegeneronVertex PharmaceuticalsAlectorCullinan TherapeuticsInnovent BiologicsiTeos TherapeuticsMersana TherapeuticsScholar RockDragonfly Therapeutics
Beyond the preview
Go deeper on Adimab.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Adimab.